Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Lijuan Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6405-0240; OpenAlex author ID A5056716164. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Prognostic value of composite inflammatory prognostic model in pancreatic cancer. Last author DOI 10.1016/j.mcp.2025.102056↗
  2. Serum Exo-EphA2 as a Potential Diagnostic Biomarker for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001660↗
  3. EphA2‑enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer. First author DOI 10.3892/mmr.2020.11384↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qian Wei · 2 shared papers, 2020–2025 · strength 0.46
  2. Li Ren · 2 shared papers, 2020 · strength 0.28
  3. Qian Wei · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.